How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/diagnostic-test-for-secondary-adrenocortical-insufficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Diagnostic Test for Secondary Adrenocortical Insufficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Test for Secondary Adrenocortical Insufficiency (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Diagnostic Test for Secondary Adrenocortical Insufficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Cortrosyn	tetracosactide	Amphastar Pharms Inc	Adrenocorticotropic Hormone [EPC]	Melanocortin receptor 4		1970-01-01
Metopirone	METYRAPONE	Esteve	Adrenal Steroid Synthesis Inhibitor [EPC]	Cytochrome P450 11B1, mitochondrial		1961-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Amphastar Pharms Inc · 1 drug in Diagnostic Test for Secondary Adrenocortical Insufficiency
Esteve · 1 drug in Diagnostic Test for Secondary Adrenocortical Insufficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Diagnostic Test for Secondary Adrenocortical Insufficiency:

Cite this brief

Drug Landscape (2026). Diagnostic Test for Secondary Adrenocortical Insufficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diagnostic-test-for-secondary-adrenocortical-insufficiency. Accessed 2026-06-10.

Diagnostic Test for Secondary Adrenocortical Insufficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing